Citations for
1ATXN3, BECN1, VCP
VCP/p97 regulates Beclin-1-dependent autophagy initiation.
Hill SM, Wrobel L, Ashkenazi A, Fernandez-Estevez M, Tan K, Bürli RW, Rubinsztein DC.
Nat Chem Biol. Apr;17(4):448-455. doi: 10.1038/s41589-020-00726-x. Epub 2021 Jan 28. 2021
2ATXN3, RNF8, VCP
The p97-Ataxin 3 complex regulates homeostasis of the DNA damage response E3 ubiquitin ligase RNF8.
Singh AN, Oehler J, Torrecilla I, Kilgas S, Li S, Vaz B, Guérillon C, Fielden J, Hernandez-Carralero E, Cabrera E, Tullis ID, Meerang M, Barber PR, Freire R, Parsons J, Vojnovic B, Kiltie AE, Mailand N, Ramadan K.
EMBO J 38(21):e102361. doi: 10.15252/embj.2019102361. Epub 2019 Oct 15. 2019
3ATXN1, ATXN2, ATXN3, ATXN7, ATXN8, SCA1, SCA2, SCA3, SCA7, SCA8
Spinocerebellar ataxias in Venezuela: genetic epidemiology and their most likely ethnic descent
Paradisi I, Ikonomu V, Arias S.
J Hum Genet. Mar;61(3):215-22. doi: 10.1038/jhg.2015.131. Epub 2015 Nov 5. 2016
4ATXN3, MJD
Sodium valproate alleviates neurodegeneration in SCA3/MJD via suppressing apoptosis and rescuing the hypoacetylation levels of histone H3 and H4.
Yi J, Zhang L, Tang B, Han W, Zhou Y, Chen Z, Jia D, Jiang H.
PLoS One 8(1):e54792. doi: 10.1371/journal.pone.0054792. Epub 2013 Jan 28. 2013
5ATXN3, BAX, BCL2L1, MJD
Ataxin-3 protects cells against H2O2-induced oxidative stress by enhancing the interaction between Bcl-XL and Bax.
Zhou L, Wang H, Wang P, Ren H, Chen D, Ying Z, Wang G.
Neuroscience 243:14-21. doi: 10.1016/j.neuroscience.2013.03.047. Epub 2013 Apr 2. 2013
6ATXN3, CAPN1, CAPN2, CAST
Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3).
Hübener J, Weber JJ, Richter C, Honold L, Weiss A, Murad F, Breuer P, Wüllner U, Bellstedt P, Paquet-Durand F, Takano J, Saido TC, Riess O, Nguyen HP.
Hum Mol Genet 22(3):508-18. doi: 10.1093/hmg/dds449. Epub 2012 Oct 24. 2013
7ATXN3
Ataxin-3 regulates aggresome formation of copper-zinc superoxide dismutase (SOD1) by editing K63-linked polyubiquitin chains.
Wang H, Ying Z, Wang G.
J Biol Chem 287(34):28576-85. doi: 10.1074/jbc.M111.299990. Epub 2012 Jul 3. 2012
8ATXN3
Expanded ATXN3 frameshifting events are toxic in Drosophila and mammalian neuron models.
Stochmanski SJ, Therrien M, Laganičre J, Rochefort D, Laurent S, Karemera L, Gaudet R, Vyboh K, Van Meyel DJ, Di Cristo G, Dion PA, Gaspar C, Rouleau GA.
Hum Mol Genet 21(10):2211-8. doi: 10.1093/hmg/dds036. Epub 2012 Feb 14. 2012
9ATXN3, VCP
Valosin-containing protein (VCP/p97) is an activator of wild-type ataxin-3.
Laço MN, Cortes L, Travis SM, Paulson HL, Rego AC.
PLoS One 7(9):e43563. doi: 10.1371/journal.pone.0043563. Epub 2012 Sep 6. 2012
10ATXN3
The role of the central flexible region on the aggregation and conformational properties of human ataxin-3.
Santambrogio C, Frana AM, Natalello A, Papaleo E, Regonesi ME, Doglia SM, Tortora P, Invernizzi G, Grandori R.
FEBS J 279(3):451-63. doi: 10.1111/j.1742-4658.2011.08438.x. Epub 2012 Jan 9. 2012
11ATXN3, PRKN
Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme.
Durcan TM, Kontogiannea M, Bedard N, Wing SS, Fon EA.
J Biol Chem 287(1):531-41. doi: 10.1074/jbc.M111.288449. Epub 2011 Nov 11. 2012
12ATXN3, MJD, PRKN
The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability.
Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Fantaneanu T, Paulson HL, Fon EA.
Hum Mol Genet 20(1):141-54. Epub 2010 Oct 11. 2011
13ATXN3, VCP
The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis.
Kuhlbrodt K, Janiesch PC, Kevei É, Segref A, Barikbin R, Hoppe T.
Nat Cell Biol 13(3):273-81. Epub 2011 Feb 13. 2011
14ATXN3, FOXO4, SOD2
FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3.
Araujo J, Breuer P, Dieringer S, Krauss S, Dorn S, Zimmermann K, Pfeifer A, Klockgether T, Wuellner U, Evert BO.
Hum Mol Genet 20(15):2928-41. Epub 2011 May 2. 2011
15ATXN3, UBE2W
Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP.
Scaglione KM, Zavodszky E, Todi SV, Patury S, Xu P, Rodríguez-Lebrón E, Fischer S, Konen J, Djarmati A, Peng J, Gestwicki JE, Paulson HL.
Mol Cell 43(4):599-612. 2011
16ATXN3, MJD
Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease.
Koch P, Breuer P, Peitz M, Jungverdorben J, Kesavan J, Poppe D, Doerr J, Ladewig J, Mertens J, Tüting T, Hoffmann P, Klockgether T, Evert BO, Wüllner U, Brüstle O.
Nature 480(7378):543-6. doi: 10.1038/nature10671. 2011
17ATXN3, MJD
Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?
Alves S, Nascimento-Ferreira I, Dufour N, Hassig R, Auregan G, Nóbrega C, Brouillet E, Hantraye P, Pedroso de Lima MC, Déglon N, de Almeida LP.
Hum Mol Genet 19(12):2380-94. Epub 2010 Mar 22.PMID: 20308049 2010
18ATXN3, MJD
The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls.
Bettencourt C, Santos C, Montiel R, Kay T, Vasconcelos J, Maciel P, Lima M.
Eur J Hum Genet 18(5):621-3. Epub 2009 Nov 25.PMID: 19935829 2010
19ATXN3
Increased transcript diversity: novel splicing variants of Machado-Joseph Disease gene (ATXN3).
Bettencourt C, Santos C, Montiel R, Costa MD, Cruz-Morales P, Santos LR, Simőes N, Kay T, Vasconcelos J, Maciel P, Lima M.
Neurogenetics eurogenetics. 2009 Aug 28. [Epub ahead of print] 2009
20ATXN3, CSNK2A1
CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3.
Mueller T, Breuer P, Schmitt I, Walter J, Evert BO, Wüllner U.
Hum Mol Genet 18(17):3334-43. Epub 2009 Jun 19.PMID: 19542537 2009
21AMFR, ATXN3, SOD1
Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation.
Ying Z, Wang H, Fan H, Zhu X, Zhou J, Fei E, Wang G.
Hum Mol Genet 18(22):4268-81. Epub 2009 Aug 6.PMID: 19661182 2009
22ATXN3
Josephin domain of ataxin-3 contains two distinct ubiquitin-binding sites.
Nicastro G, Masino L, Esposito V, Menon RP, De Simone A, Fraternali F, Pastore A.
Biopolymers 91(12):1203-14. doi: 10.1002/bip.21210. 2009
23ATXN3, MJD
Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease.
Alves S, Régulier E, Nascimento-Ferreira I, Hassig R, Dufour N, Koeppen A, Carvalho AL, Simőes S, de Lima MC, Brouillet E, Gould VC, Déglon N, de Almeida LP.
Hum Mol Genet 17(14):2071-83. Epub 2008 Apr 1. 2008
24ATXN3
The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains.
Winborn BJ, Travis SM, Todi SV, Scaglione KM, Xu P, Williams AJ, Cohen RE, Peng J, Paulson HL.
J Biol Chem 283(39):26436-43. Epub 2008 Jul 3. 2008
25ATXN3
Josephin domain-containing proteins from a variety of species are active de-ubiquitination enzymes.
Tzvetkov N, Breuer P.
Biol Chem 388(9):973-8. 2007
26ATXN3, NEDD8
NEDD8: a new ataxin-3 interactor.
Ferro A, Carvalho AL, Teixeira-Castro A, Almeida C, Tomé RJ, Cortes L, Rodrigues AJ, Logarinho E, Sequeiros J, Macedo-Ribeiro S, Maciel P.
Biochim Biophys Acta 1773(11):1619-27. Epub 2007 Aug 24.PMID: 17935801 2007
27ATXN3, PSMC5
p45, an ATPase subunit of the 19S proteasome, targets the polyglutamine disease protein ataxin-3 to the proteasome.
Wang H, Jia N, Fei E, Wang Z, Liu C, Zhang T, Fan J, Wu M, Chen L, Nukina N, Zhou J, Wang G.
J Neurochem 101(6):1651-61. Epub 2007 Feb 14. 2007
28MJD, ATXN3
Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3.
Haacke A, Broadley SA, Boteva R, Tzvetkov N, Hartl FU, Breuer P.
Hum Mol Genet 15(4):555-68. Epub 2006 Jan 11. 2006
29MJD, ATXN3
A multistep mutation mechanism drives the evolution of the CAG repeat at MJD/SCA3 locus.
Martins S, Calafell F, Wong VC, Sequeiros J, Amorim A.
Eur J Hum Genet 14(8):932-40. Epub 2006 May 17. 2006
30ATXN3, VCP
Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates.
Zhong X, Pittman RN.
Hum Mol Genet 15(16):2409-20. Epub 2006 Jul 5. 2006
31SCA1, ATXN1, SCA2, ATXN2, MJD, ATXN3, SCA6, CACNA1A, SCA7, ATXN7, SCA17, TBP, DRPLA, ATN1, SBMA, AR
Transcriptional alterations and chromatin remodeling in polyglutamine diseases.
Helmlinger D, Tora L, Devys D.
Trends Genet 22(10):562-70. Epub 2006 Sep 5. 2006
32ATXN3
Ataxin-3 is subject to autolytic cleavage.
Mauri PL, Riva M, Ambu D, De Palma A, Secundo F, Benazzi L, Valtorta M, Tortora P, Fusi P.
FEBS J 273(18):4277-86. 2006
33ATXN3, MJD
Ribosomal frameshifting on MJD-1 transcripts with long CAG tracts.
Toulouse A, Au-Yeung F, Gaspar C, Roussel J, Dion P, Rouleau GA.
Hum Mol Genet 14(18):2649-60. Epub 2005 Aug 8. 2005
34FXN, FRDA, FRAXA, FMR1, FRAXE, ATXN1, SCA1, ATXN2, SCA2, ATXN3, MJD, ATXN7, SCA7, SCA6, CACNA1A, SCA17, TBP, DRPLA, ATN1, AR, SBMA, DM1, DMPK, DM2, CNBP, SCA10, ATXN10, SCA12, PPP2R2B, SCA8, ATXN8OS
Diseases of unstable repeat expansion: mechanisms and common principles.
Gatchel JR, Zoghbi HY.
Nat Rev Genet 6(10):743-55. Review. 2005
35ATXN3
Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism.
Warrick JM, Morabito LM, Bilen J, Gordesky-Gold B, Faust LZ, Paulson HL, Bonini NM.
Mol Cell 18(1):37-48. 2005
36ATXN3
Molecular architecture of CAG repeats in human disease related transcripts.
Michlewski G, Krzyzosiak WJ.
J Mol Biol 340(4):665-79. 2004
37ATXN2, ATXN3
Structural and functional analysis of ataxin-2 and ataxin-3.
Albrecht M, Golatta M, Wullner U, Lengauer T.
Eur J Biochem 271(15):3155-70. 2004
38ATXN3
Defining a metabolic phenotype in the brain of a transgenic mouse model of spinocerebellar ataxia 3.
Griffin JL, Cemal CK, Pook MA.
Physiol Genomics 16(3):334-40. 2004
39ATXN3, UBE4B
Molecular clearance of ataxin-3 is regulated by a mammalian E4.
Matsumoto M, Yada M, Hatakeyama S, Ishimoto H, Tanimura T, Tsuji S, Kakizuka A, Kitagawa M, Nakayama KI.
EMBO J 23(3):659-69. Epub 2004 Jan 29. 2004
40ATXN3
Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3.
Chow MK, Mackay JP, Whisstock JC, Scanlon MJ, Bottomley SP.
Biochem Biophys Res Commun 322(2):387-94. 2004
41ATXN3
Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.
Masino L, Nicastro G, Menon RP, Dal Piaz F, Calder L, Pastore A.
J Mol Biol 344(4):1021-35. 2004
42ATXN3, MJD
The pathogenesis of Machado Joseph Disease: a high manganese/low magnesium initiated CAG expansion mutation in susceptible genotypes?
Purdey M.
J Am Coll Nutr 23(6):715S-29S. Review. 2004
43ATXN3, VCP
Molecular analyses of Machado-Joseph disease.
Kobayashi T, Kakizuka A.
Cytogenet Genome Res 100(1-4):261-75. No abstract available. 2003
44ATXN3, ATXN7
Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics.
Scheel H, Tomiuk S, Hofmann K.
Hum Mol Genet 12(21):2845-52. Epub 2003 Aug 27. 2003
45ATXN3
The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity.
Burnett B, Li F, Pittman RN.
Hum Mol Genet 12(23):3195-205. Epub 2003 Oct 14. 2003
46ATXN3
Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis.
Doss-Pepe EW, Stenroos ES, Johnson WG, Madura K.
Mol Cell Biol 23(18):6469-83. 2003
47MJD, ATXN3
Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3.
Evert BO, Vogt IR, Vieira-Saecker AM, Ozimek L, de Vos RA, Brunt ER, Klockgether T, Wullner U.
J Neuropathol Exp Neurol 62(10):1006-18. 2003
48ATXN3
The human MJD gene: genomic structure and functional characterization of the promoter region.
Schmitt I, Evert BO, Khazneh H, Klockgether T, Wuellner U.
Gene 314:81-8. 2003
49ATXN3
The genomic structure and expression of MJD, the Machado-Joseph disease gene.
Ichikawa Y, Goto J, Hattori M, Toyoda A, Ishii K, Jeong SY, Hashida H, Masuda N, Ogata K, Kasai F, Hirai M, Maciel P, Rouleau GA, Sakaki Y, Kanazawa I.
J Hum Genet 46(7):413-22. 2001
50ATXN3
Cell cycle arrest enhances the in vitro cellular toxicity of the truncated machado-joseph disease gene product with an expanded polyglutamine stretch.
Yoshizawa T, Yamagishi Y, Koseki N, Goto J, Yoshida H, Shibasaki F, Shoji S, Kanazawa I.
Hum Mol Genet 9(1):69-78 2000
51ATXN3, RAD23A, RAD23BL
Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B.
Wang G, Sawai N, Kotliarova S, Kanazawa I, Nukina N.
Hum Mol Genet 9(12):1795-803. 2000
52ATXN3
Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.
Fujigasaki H, Uchihara T, Koyano S, Iwabuchi K, Yagishita S, Makifuchi T, Nakamura A, Ishida K, Toru S, Hirai S, Ishikawa K, Tanabe T, Mizusawa H.
Exp Neurol 165(2):248-56. 2000
53ATXN3
Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
Chai Y, et al.
Hum Mol Genet 8(4):673-82. 1999
54ATXN3
Study of three intragenic polymorphisms in the Machado-Joseph disease gene (MJD1) in relation to genetic instability of the (CAG)n tract.
Maciel P, et al.
Eur J Hum Genet 7(2):147-56. 1999
55ERDA1, ATXN3, ATXN1, ATXN2, ATXN7, TCF4
Cis-acting modifiers of expanded CAG/CTG triplet repeat expandability: associations with flanking GC content and proximity to CpG islands.
Brock GJ, et al.
Hum Mol Genet 8(6):1061-7. 1999
56ATXN3
High level expression of expanded full-length ataxin-3 in vitro causes cell death and formation of intranuclear inclusions in neuronal cells.
Evert BO, et al.
Hum Mol Genet 8(7):1169-1176. 1999
57ATXN3
Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix.
Perez MK, Paulson HL, Pittman RN.
Hum Mol Genet 8(13):2377-85 1999
58ATXN3, ATXN1
Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3.
Burk K, Fetter M, Abele M, Laccone F, Brice A, Dichgans J, Klockgether T.
J Neurol 246(9):789-97 1999
59ATXN3
Ataxin-3 is transported into the nucleus and associates with the nuclear matrix.
Tait D, et al.
Hum Mol Genet 7 : 991-997. 1998
60ATXN3
Different behavior in the paternally vs. maternally inherited mutated allele in Brazilian Machado-Joseph (MJD1) families.
Iughetti P, et al.
Am J Med Genet 77 : 246-248. 1998
61ATXN3
An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients.
Schmidt T, et al.
Brain Pathol 8 : 669-679. 1998
62ATXN3
Non-mendelian transmission at the Machado-Joseph disease locus in normal females : preferential transmission of alleles with smaller CAG repeats.
Rubinsztein DC, et al.
J Med Genet 34 : 234-236. 1997
63ATXN3
Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain.
Paulson HL, et al.
Ann Neurol 41 : 453-462. 1997
64ATXN3
Mosaicism of the CAG repeat in CNS tissue in relation to age at death in spinocerebellar ataxia type 1 and Machado-Joseph disease patients.
Maciel P, et al.
Am J Hum Genet 60 : 993-996. 1997
65ATXN3
Machado-Joseph disease gene product identified in lymphocytes and brain.
Wang G, et al.
Biochem Biophys Res Commun 233 : 476-479. 1997
66ATXN3
Single sperm analysis of the CAG repeats in the gene for Machado-Joseph disease (MJD1): evidence for non-Mendelian transmission of the MJD1 gene and for the effect of the intragenic CGG/GGG polymorphism on the intergenerational instability.
Takiyama Y, Sakoe K, Soutome M, Namekawa M, Ogawa T, Nakano I, Igarashi S, Oyake M, Tanaka H, Tsuji S, Nishizawa M.
Hum Mol Genet 6(7):1063-8. 1997
67ATXN3
Linkage disequilibrium between the spinocerebellar ataxia 3/Machado-Joseph disease mutation and two intragenic polymorphisms, one of which, X359Y, affects the stop codon.
Stevanin G, Lebre AS, Mathieux C, Cancel G, Abbas N, Didierjean O, Durr A, Trottier Y, Agid Y, Brice A.
Am J Hum Genet 60(6):1548-52. 1997
68ATXN3
Machado-Joseph disease gene products carrying different carboxyl termini.
Goto J, Watanabe M, Ichikawa Y, Yee SB, Ihara N, Endo K, Igarashi S, Takiyama Y, Gaspar C, Maciel P, Tsuji S, Rouleau GA, Kanazawa I.
Neurosci Res 28(4):373-7. 1997
69ATXN3
Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3.
Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS, Vig P, Mandel JL, Fischbeck KH, Pittman RN.
Neuron 19(2):333-44. 1997
70ATXN3
Mutations in American families with spinocerebellar ataxia (SCA) type 3 : SCA3 is allelic to Machado-Joseph disease.
Higgins JJ, et al.
Neurology 46 : 208-213. 1996
71ATN1, ATXN3
Non-mendelian transmission in dentatorubral-pallidoluysian atrophy and Machado-Joseph disease : the mutant allele is preferentially transmitted in male meiosis.
Ikeuchi T, et al.
Am J Hum Genet 58 : 730-733. 1996
72ATXN3
Different origins of mutations at the Machado-Joseph locus (MJD1).
Iughetti P, et al.
J Med Genet 33 : 439-440. 1996
73ATXN3
Machado-Joseph disease : correlation between the clinical features, the CAG repeat length and homozygosity for the mutation.
Lerer I, et al.
Eur J Hum Genet 4 : 3-7. 1996
74ATXN3
Intergenerational instability of the CAG repeat of the gene for Machado-Joseph disease (MJD1) is affected by the genotype of the normal chromosome : implications for the molecular mechanisms of the instability of the CAG repeat.
Igarashi S, et al.
Hum Mol Genet 5 : 923-932. 1996
75ATXN3
A familial factor independent of CAG repeat length influences age at onset of Machado-Joseph disease.
DeStefano AL, et al.
Am J Hum Genet 59 : 119-127. 1996
76ATXN3
Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo.
Ikeda H, et al.
Nat Genet 13 : 196-202. 1996
77ATXN3
Strong linkage disequilibrium and haplotype analysis in Japanese pedigrees with Machado-Joseph disease.
Endo K, et al.
Am J Med Genet 67 : 437-444. 1996
78ATXN3
Linkage disequilibrium analysis in Machado-Joseph disease patients of different ethnic origins.
Gaspar C, et al.
Hum Genet 98 : 620-624. 1996
79ATXN3
Relationship of (CAG)nC configuration to repeat instability of the Machado-Joseph disease gene.
Matsumura R, et al.
Hum Genet 98 : 643-645. 1996
80ATXN3
Molecular and clinical correlations in spinocerebellar ataxia type 3 and Machado-Joseph disease.
Matilla T, McCall A, Subramony SH, Zoghbi HY.
Ann Neurol 38 : 68-72. 1995
81ATXN3
Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia 3/Machado-Joseph disease locus.
Cancel G, Abbas N, Stevanin G, Durr A, Chneiweiss H, Neri C, Duyckaerts C, Penet C, Cann HM, Agid Y, et al.
Am J Hum Genet 57 : 809-816. 1995
82ATXN3
Characterisation of the unstable expanded CAG repeat in the MJD1 gene in four Brazilian families of Portuguese descent with Machado-Joseph disease.
Stevanin G, Cassa E, Cancel G, Abbas N, Durr A, Jardim E, Agid Y, Sousa PS, Brice A.
J Med Genet 32 : 827-830. 1995
83ATXN3
Spinocerebellar ataxia, type 3 (SCA3) is genetically identical to Machado-Joseph disease (MJD).
Haberhausen G, Damian MS, Leweke F, Muller U.
J Neurol Sci 132 : 71-75. 1995
84ATXN3
Linkage disequilibrium at the Machado-Joseph disease/spinal cerebellar ataxia 3 locus : evidence for a common founder effect in French and Portuguese-Brazilian families as well as a second ancestral Portuguese-Azorean mutation.
Stevanin G, Cancel G, Didierjean O, Durr A, Abbas N, Cassa E, Feingold J, Agid Y, Brice A.
Am J Hum Genet 57 : 1247-1250. 1995
85ATXN3
Refinement by linkage analysis in two large families of the candidate region of the third locus (SCA3) for autosomal dominant cerebellar ataxia type 1.
Verschuuren-Bemelmans CC, Brunt ER, Burton M, Mensink RG, van der Meulen MA, Smit NH, Stolte-Dijkstra I, Buys CH, Scheffer H.
Hum Genet 96 : 691-694. 1995
86ATXN3
Detection of the Machado-Joseph disease/spinocerebellar ataxia three trinucleotide repeat expansion in families with autosomal dominant motor disorders, including the Drew family of Walworth.
Giunti P, et al.
Brain 118 : 1077-1085. 1995
87ATXN3
Dopa-responsive parkinsonism phenotype of Machado-Joseph disease : confirmation of 14q CAG expansion.
Tuite PJ, et al.
Ann Neurol 38 : 684-687. 1995
88ATXN3
Machado Joseph disease maps to the same region of chromosome 14 as the spinocerebellar ataxia type 3 locus.
Twist EC, et al.
J Med Genet 32 : 25-31. 1995
89ATXN3
Molecular features of the CAG repeats and clinical manifestation of Machado-Joseph disease.
Maruyama H, et al.
Hum Mol Genet 4 : 807-812. 1995
90ATXN3
Trinucleotide expansion within the MJD1 gene presents clinically as spinocerebellar ataxia and occurs most frequently in German SCA patients.
Schšls L, et al.
Hum Mol Genet 4 : 1001-1005. 1995
91ATXN3
Correlation between CAG repeat length and clinical features in Machado-Joseph disease.
Maciel P, et al.
Am J Hum Genet 57 : 54-61. 1995
92ATXN3
Evidence for inter-generational instability in the CAG repeat in the MJD1 gene and for conserved haplotypes at flanking markers amongst Japanese and Caucasian subjects with Machado-Joseph disease.
Takiyama Y, et al.
Hum Mol Genet 4 : 1137-1146. 1995
93ATXN3
Molecular analysis of three patients with interstitial deletions of chromosome band 14q31.
Byth BC, et al.
J Med Genet 32 : 564-567. 1995
94AR, ATXN3, ATXN1
Sequence variation and size ranges of CAG repeats in the Machado-Joseph disease, spinocerebellar ataxia type 1 and androgen receptor genes.
Rubinsztein DC, et al.
Hum Mol Genet 4 : 1585-1590. 1995
95ATXN3
Mapping of the gene for Machado-Joseph disease within a 3.6-cM interval flanked by D14S291/D14S280 and D14S81, on the basis of studies of linkage and linkage disequilibrium in 24 Japanese families.
Sasaki H, et al.
Am J Hum Genet 56 : 231-242. 1995
96ATXN3
The gene for spinal cerebellar ataxia 3 (SCA3) is located in a region of ~3 cM on chromosome 14q24.3-q32.2.
Stevanin G, et al.
Am J Hum Genet 56 : 193-201. 1995
97ATN1, ATXN3
Is DRPLA also linked to 14q?
Cancel G, et al.
Nat Genet 6 : 8. 1994
98ATXN3
A third locus for autosomal dominant cerebellar ataxia type I maps to chromosome 14q24.3-qter : evidence for the existence of a fourth locus.
Stevanin G, et al.
Am J Hum Genet 54 : 11-20. 1994
99ATXN3
Machado Joseph disease is not an allele of the spinocerebellar ataxia 2 locus.
Twist EC, et al.
Hum Genet 93 : 335-338. 1994
100ATXN3
Genetic linkage studies of Machado-Joseph disease with chromosome 14q STRPs in 16 Portuguese-Azorean kindreds.
Sequeiros J, et al.
Genomics 21 : 645-648. 1994
101ATXN3
A clinical and pathologic study of a large Japanese family with Machado-Joseph disease tightly linked to the DNA markers on chromosome 14q.
Takiyama Y, et al.
Neurology 44 : 1302-1308. 1994
102ATXN3
A linkage study of Machado-Joseph disease - Refining the localisation of the gene. (abstr)
Gaspar C, et al.
Am J Hum Genet 55 : A348. 1994
103ATXN3, MJDL1, MJDL2, ATXN3L
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.
Kawaguchi Y, et al.
Nat Genet 8 : 221-228. 1994
104ATXN3
Machado-Joseph disease in pedigrees of Azorean descent is linked to chromosome 14.
St George-Hyslop P, Rogaeva E, Huterer J, Tsuda T, Santos J, Haines JL, Schlumpf K, Rogaev EI, Liang Y, McLachlan DR, et al.
Am J Hum Genet 55 : 120-125. 1994
105ATXN3
The gene for Machado-Joseph disease maps to human chromosome 14q.
Takiyama Y, et al.
Nat Genet 4 : 300-303. 1993
106ATXN1, ATXN2, ATXN3
Genetic heterogeneity of autosomal dominant cerebellar ataxia type I : evidence for the existence of a third locus.
Stevanin G, et al.
Hum Mol Genet 2 : 1483-1485. 1993
107ATXN3
Machado-Joseph disease : linkage analysis between the loci for the disease and 18 protein markers.
Myers SM, et al.
Cytogenet Cell Genet 43 : 226-228. 1986